TAM
WST icon

Tucker Asset Management’s West Pharmaceutical WST Stock Holding History

Tucker Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8
Closed -$2.2K – 1033
2025
Q4 		$2.2K Buy
+8
New +$2.19K ﹤0.01% 834
2025
Q1 		– Sell
-8
Closed -$2.62K – 948
2024
Q4 		$2.62K Hold
8
– – ﹤0.01% 1155
2024
Q3 		$2.4K Hold
8
– – ﹤0.01% 1129
2024
Q2 		$2.63K Buy
+8
New +$2.83K ﹤0.01% 1250
2024
Q1 		– Sell
-21
Closed -$7.39K – 1783
2023
Q4 		$7.39K Hold
21
– – ﹤0.01% 782
2023
Q3 		$7.88K Hold
21
– – ﹤0.01% 719
2023
Q2 		$8.03K Hold
21
– – ﹤0.01% 581
2023
Q1 		$7.28K Buy
+21
New +$6.14K ﹤0.01% 620
2022
Q1 		– Sell
-18
Closed -$8.48K – 618
2021
Q4 		$8.48K Buy
+18
New +$7.75K ﹤0.01% 230

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tucker Asset Management's WST Position: Q1 2026 in Review

Tucker Asset Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 8 shares — an estimated $2.2K sold.

Tucker Asset Management first reported a position in WST in Q4 2021 and held it in 9 quarters. The position peaked at $8.48K in Q4 2021. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Tucker Asset Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Tucker Asset Management sold 8 West Pharmaceutical shares in Q1 2026, an estimated $2.2K.
  • Tucker Asset Management first reported a position in West Pharmaceutical in Q4 2021 and held it in 9 quarters.
  • Tucker Asset Management's West Pharmaceutical position peaked at $8.48K in Q4 2021.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.